Share-based Payment Arrangement, Expense in USD of Q32 Bio Inc. from Q1 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Q32 Bio Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q1 2017 to Q3 2025.
  • Q32 Bio Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1.18M, a 14.9% decline year-over-year.
  • Q32 Bio Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $5.04M, a 37.8% increase year-over-year.
  • Q32 Bio Inc. annual Share-based Payment Arrangement, Expense for 2024 was $4.39M, a 207% increase from 2023.
  • Q32 Bio Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.43M, a 89.1% decline from 2022.
  • Q32 Bio Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.1M, a 24.3% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Q32 Bio Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $5.04M $1.18M -$206K -14.9% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $5.24M $1.27M -$68K -5.09% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $5.31M $1.34M +$925K +222% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $4.39M $1.25M +$730K +140% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 $3.66M $1.38M +$1.08M +359% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 $2.58M $1.34M +$1.03M +331% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 $1.55M $417K +$121K +40.9% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 $1.43M $521K -$2.57M -83.1% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 $4M $301K -$2.47M -89.1% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 $6.47M $310K -$2.83M -90.1% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $9.3M $296K -$3.76M -92.7% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $13.1M $3.09M -$1.57M -33.8% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 $14.6M $2.77M -$1.46M -34.4% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $16.1M $3.14M -$1.33M -29.7% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $17.4M $4.05M +$168K +4.33% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $17.2M $4.66M +$1.1M +30.7% 01 Oct 2021 31 Dec 2021 10-K 09 Mar 2023
Q3 2021 $16.1M $4.23M +$880K +26.3% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $15.3M $4.47M +$1.02M +29.6% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 $14.2M $3.88M +$1M +34.7% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022
Q4 2020 $13.2M $3.57M +$1.13M +46.4% 01 Oct 2020 31 Dec 2020 10-K 23 Mar 2022
Q3 2020 $12.1M $3.35M +$1.36M +68.4% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021
Q2 2020 $10.8M $3.45M +$1.48M +75.3% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $9.28M $2.88M +$1.64M +132% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q4 2019 $7.64M $2.44M +$1.48M +155% 01 Oct 2019 31 Dec 2019 10-K 11 Mar 2021
Q3 2019 $6.15M $1.99M +$1.27M +176% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $4.89M $1.97M +$1.4M +246% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $3.49M $1.24M +$863K +227% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 $2.62M $955K +$815K +583% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 $1.81M $719K +$661K +1142% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 $1.15M $569K +$538K +1761% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 $608K $380K +$352K +1273% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019
Q4 2017 $256K $140K 01 Oct 2017 31 Dec 2017 10-K 12 Mar 2019
Q3 2017 $57.9K 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018
Q2 2017 $30.6K 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 $27.7K 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018

Q32 Bio Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.39M +$2.96M +207% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 $1.43M -$11.6M -89.1% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 $13.1M -$4.19M -24.3% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2024
2021 $17.2M +$4M +30.2% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023
2020 $13.2M +$5.61M +73.5% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2022
2019 $7.64M +$5.01M +191% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021
2018 $2.62M +$2.37M +925% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020
2017 $256K 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.